According to PainReform's latest financial reports the company has a price-to-book ratio of 0.3229.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 0.5920 | 48.66% |
2022-12-31 | 0.3982 | -48.35% |
2021-12-31 | 0.7710 | -67.83% |
2020-12-31 | 2.40 | |
2019-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | 0.6372 | 97.33% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | 1.96 | 506.65% | ๐บ๐ธ USA |